Viridian Therapeutics, Inc.\DE (VRDN) Gross Margin Growth (1y) (2014 - 2016)
Viridian Therapeutics, Inc.\DE (VRDN) Gross Margin Growth (1y) (2014 - 2016) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 372.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -5.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -165.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 236.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Viridian Therapeutics, Inc.\DE | 229.55 Mn | 229.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -6,676.00 |
| Sep 30, 2016 | -2,077.00 |
| Jun 30, 2016 | 3,605.00 |
| Mar 31, 2016 | 4,924.00 |
| Dec 31, 2015 | 5,004.00 |
| Sep 30, 2015 | 486.00 |
| Jun 30, 2015 | -3,352.00 |
| Mar 31, 2015 | -5,083.00 |
| Sep 30, 2014 | 158.00 |
| Jun 30, 2014 | -1,018.00 |